June 18 (Reuters) - The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data and other evidence. The ...
Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic modernization of how testosterone therapy is prescribed, ...
The Department of Health and Human Services (HHS) announced plans on June 18 to update label information for testosterone replacement therapy (TRT) products, marking a significant shift in policy.
RALEIGH, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a specialty pharmaceutical company advancing the science of testosterone therapy and hormone health, today welcomed an ...
HHS announced it would request updates to the warning labels for testosterone replacement therapy products. Malorny/Getty ImagesThis article originally appeared onHealthline The Department of Health ...
(MENAFN- GlobeNewsWire - Nasdaq) The FDA's second major labeling update in 16 months - after its February 2025 removal of the cardiovascular boxed warning - marks a historic modernization of how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results